Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/26 04:59:34 pm
130.375 EUR   -1.12%
10/21MERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
10/21MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Independant Research keeps its Buy rating

share with twitter share with LinkedIn share with facebook
10/01/2020 | 09:48am EDT

Independant Research analyst Tobias Gottschalt maintains his Buy rating on the stock. The target price differs slightly and is now set at EUR 139 versus EUR 138.

© MarketScreener with dpa-AFX Analyser 2020

share with twitter share with LinkedIn share with facebook
All news about MERCK KGAA
10/21MERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
10/21MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
10/15MERCK : Global Head of R&D for Healthcare to Retire
DJ
10/15Global Glycobiology Market to Rise at 14.64% between 2020 and 2027
AQ
10/13MERCK : Launches Cell and Gene Therapy Platform
DJ
10/13MERCK KGAA : Barclays withdraws its Sell rating
MD
10/12Merck KgaA Licenses Genome-Editing Technology to Two Companies
DJ
10/09MERCK : Precigen Shares Gain 20% as Germany's Merck Raises Stake
DJ
10/09MERCK : Raises Precigen Stake to 14.8% With Note Conversion
DJ
More news
Financials
Sales 2020 17 304 M 20 441 M 20 441 M
Net income 2020 1 706 M 2 015 M 2 015 M
Net Debt 2020 10 847 M 12 814 M 12 814 M
P/E ratio 2020 32,0x
Yield 2020 1,01%
Capitalization 57 325 M 67 745 M 67 717 M
EV / Sales 2020 3,94x
EV / Sales 2021 3,66x
Nbr of Employees 57 523
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 126,24 €
Last Close Price 131,85 €
Spread / Highest target 13,8%
Spread / Average Target -4,25%
Spread / Lowest Target -23,4%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA25.15%67 857
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD104.14%21 282
KYOWA KIRIN CO., LTD.1.79%13 360
BETTA PHARMACEUTICALS CO., LTD.59.51%6 264
YUHAN CORPORATION24.74%3 346
RECIPHARM AB (PUBL)16.10%1 751